Medicine and Dentistry
Inflammatory Bowel Disease
85%
Cohort Analysis
66%
Meta-Analysis
32%
Hazard Ratio
26%
Malignant Neoplasm
17%
Immunosuppressive Treatment
17%
Crohn's Disease
17%
Ulcerative Colitis
16%
Pediatrics
16%
Cervical Cancer
16%
Genital Wart
16%
mRNA Vaccine
16%
Inflammatory Disorder
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Immunosuppressive Drug
16%
Human Immunodeficiency Virus
16%
Infectious Mononucleosis
16%
Infection
12%
Immunosuppressant
10%
Diagnosis
9%
Diseases
7%
Patient with Inflammatory Bowel Disease
7%
Random Effects Model
5%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
100%
Cohort Study
68%
Crohn's Disease
19%
Mercaptopurine
19%
Tumor Necrosis
18%
Combination Therapy
18%
Ulcerative Colitis
17%
Malignant Neoplasm
17%
Immunosuppressive Agent
17%
Inflammatory Disease
16%
Uterine Cervix Cancer
16%
Initiation Factor
16%
SARS Coronavirus
16%
mRNA Vaccine
16%
Mononucleosis
16%
Disease
7%
Infection
6%
Random Effects Model
6%
Keyphrases
Inflammatory Bowel Disease
40%
Meta-analysis
32%
Pediatric Onset
21%
Review Analysis
17%
Thiopurines
17%
Population-based Study
16%
Cancer Development
16%
SARS-CoV-2 mRNA Vaccine
16%
Inflammatory Bowel Disease Treatment
16%
Anti-tumor Necrosis Factor (anti-TNF)
16%
Hazard Ratio
16%
Antibody Profiling
16%
VirScan
16%
Phage Immunoprecipitation Sequencing
10%
Adjusted Hazard Ratio
9%
Confidence Interval
9%
Antenatal Clinic
8%
Sexual Health Clinic
8%
Genitourinary Medicine
8%
Random Effects Model
7%
MEDLINE
7%
Embase
7%
Crohn's Disease
6%
Ulcerative Colitis
6%
Population-representative
6%
Bidirectional Association
5%
Human Immunodeficiency Virus Negative
5%
Disease Mechanisms
5%
Bowel Dysfunction
5%
Clinically Significant
5%
Systematic Literature Review
5%
Subgroup Analysis
5%
IBD Patients
5%
IBD Diagnosis
5%
